MIRA INFORM REPORT

 

 

 

Report Date :

23.09.2008

 

IDENTIFICATION DETAILS

 

Name :

PHARMA MONDIAL LTD.

 

 

Registered Office :

P.K. 30 Cihangir Lefkosa Mersin Northern Cyprus

 

 

Country :

Turkey

 

 

Date of Incorporation :

15.03.1990

 

 

Legal Form :

Limited Company

 

 

Line of Business :

Manufacture and Trade of Medicine

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Small Company

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 


 

REMARKS: The company is not located in Turkey. It is in Northern Cyprus Turkish Republic so, there is no data for payment behavior.

 

COMPANY IDENTIFICATION

 

NAME

:

PHARMA MONDIAL LTD.

ADDRESS

:

Head Office&Production Plant: P.K. 30 Cihangir Lefkosa Mersin Northern Cyprus Turkish Republic

PHONE NUMBER

:

90-392-232 41 80

FAX NUMBER

:

90-392-232 41 75

 

 

LEGAL STATUS AND HISTORY

 

TAX NO

:

MS 3709

REGISTERED OFFICE

:

Northern Cyprus Chamber of Commerce

DATE ESTABLISHED

:

15.03.1990

LEGAL FORM

:

Limited Company

TYPE OF COMPANY

:

Private

REGISTERED CAPITAL

:

In Turkish Republic of Northern Cyprus, companies are not obliged to register the capital increases at Commercial Registry. The subject company has declared the capital is YTL 4,302,915. There is no certification for this figure.

 

 

OWNERSHIP / MANAGEMENT

 

SHAREHOLDERS

:

Feridun Adahan

Mustafa Ekrem

Sureyya Adahan

 

69 %

26 %

  5 %

GROUP PARENT COMPANY

 

:

None

SISTER COMPANIES

:

Sodhan Ltd. Sti.

 

DIRECTORS

 

:

Feridun Adahan

General Manager

 

 

 

OPERATIONS

 

BUSINESS ACTIVITIES

:

Manufacture and trade of medicine

 

SECTOR

 

:

Chemicals

NUMBER OF EMPLOYEES

:

20

 

NET SALES

:

n.a.

 

 

REMARKS ON NET SALES

:

The subject strictly declines to give us an authorization to gather its financial data. As the subject’s shares are not open to public it is not obliged to announce its data.

 

IMPORT COUNTRIES

:

India, UK, Germany, Italy, Turkey

 

MERCHANDISE IMPORTED

 

:

Raw materials of medicine

 

EXPORT COUNTRIES

 

:

Turkey, UK, Germany

PREMISES

:

Head Office&Production Plant: P.K. 30 Cihangir Lefkosa Mersin Northern Cyprus Turkish Republic (owned)

 

FIXED CAPITAL INVESTMENTS

:

None

 

 

FINANCE

 

MAIN DEALING BANKERS

:

Credit West Kucuk Kaymakli branch in Northern Cyprus Turkish Republic

Garanti Bankasi Lefkosa branch in Northern Cyprus Turkish Republic

 

 

 

COMMENT ON FINANCIAL POSITION

 

GENERAL FINANCIAL

POSITION

 

Undetermined; the firm declines to give us an authorization to gather its financial data. As the shares of the firm are not open to public, it is not obliged to announce its data.

 

 

 

 

Incr. in producers’ price index

 

Average YTL/$

Average YTL/EUR

Average YTL/GBP

(2007)

5.94 %

1.3075

1.7901

2.6133

(1.1.-31.08.2008)

12.49 %

1.2121

1.8537

2.3867

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.72

UK Pound

1

Rs.84.81

Euro

1

Rs.67.60

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions